Free Trial

Best Growth Stocks To Watch Now - May 27th

Novo Nordisk A/S logo with Medical background

Novo Nordisk A/S, BlackRock, and Blackstone are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to increase their revenues and earnings at a faster-than-average rate compared to the broader market. Such firms typically reinvest most of their profits into research, development, and expansion rather than paying out dividends, making them more volatile but offering the potential for significant capital appreciation. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NVO traded up $3.21 during trading hours on Tuesday, reaching $70.56. 6,445,985 shares of the company traded hands, compared to its average volume of 6,700,923. The stock has a market capitalization of $316.62 billion, a P/E ratio of 21.43, a P/E/G ratio of 0.90 and a beta of 0.65. The business has a fifty day moving average price of $66.07 and a 200-day moving average price of $82.47. Novo Nordisk A/S has a 12-month low of $57.00 and a 12-month high of $148.15. The company has a quick ratio of 0.55, a current ratio of 0.74 and a debt-to-equity ratio of 0.62.

Read Our Latest Research Report on NVO

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

NYSE BLK traded up $14.69 on Tuesday, reaching $977.87. 203,406 shares of the company's stock traded hands, compared to its average volume of 691,994. The stock has a 50 day moving average price of $921.10 and a 200-day moving average price of $976.41. The firm has a market cap of $151.50 billion, a price-to-earnings ratio of 23.28, a P/E/G ratio of 1.90 and a beta of 1.41. BlackRock has a fifty-two week low of $752.30 and a fifty-two week high of $1,084.22. The company has a debt-to-equity ratio of 0.45, a quick ratio of 5.23 and a current ratio of 5.23.

Read Our Latest Research Report on BLK

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

Shares of BX traded up $2.88 during mid-day trading on Tuesday, hitting $139.00. 1,188,810 shares of the company were exchanged, compared to its average volume of 3,784,104. Blackstone has a 1-year low of $115.66 and a 1-year high of $200.96. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.71 and a current ratio of 0.67. The company has a 50 day moving average of $136.75 and a 200-day moving average of $160.04. The stock has a market cap of $101.42 billion, a price-to-earnings ratio of 38.30, a price-to-earnings-growth ratio of 1.07 and a beta of 1.67.

Read Our Latest Research Report on BX

Featured Articles

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines